1,000 patients treated with OssDesign spinal bone graft

Biologics

OssDesign's Catalyst nanosynthetic bone graft has been used in 1,000 patients, the medtech company said May 9.

In January, the comapny reached 500 cases with Catalyst, according to a news release. It's designed for spinal fusions and is made of a proprietary nanocrystalline structure that's resorbed and replaced over time.

The bone graft was launched in the U.S. in August 2021.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers